DK1546188T3 - P53-bindende T-cellereceptormolekyler og anvendelser deraf - Google Patents

P53-bindende T-cellereceptormolekyler og anvendelser deraf

Info

Publication number
DK1546188T3
DK1546188T3 DK02746470T DK02746470T DK1546188T3 DK 1546188 T3 DK1546188 T3 DK 1546188T3 DK 02746470 T DK02746470 T DK 02746470T DK 02746470 T DK02746470 T DK 02746470T DK 1546188 T3 DK1546188 T3 DK 1546188T3
Authority
DK
Denmark
Prior art keywords
molecules
protein
tcr
cell receptor
binding
Prior art date
Application number
DK02746470T
Other languages
Danish (da)
English (en)
Inventor
Jon A Weidanz
Elizabeth L Thomson
Linda A Sherman
Kimberlyn F Card
Hing C Wong
Original Assignee
Altor Bioscience Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Altor Bioscience Corp filed Critical Altor Bioscience Corp
Application granted granted Critical
Publication of DK1546188T3 publication Critical patent/DK1546188T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503Immunoglobulin superfamily
    • C07K14/7051T-cell receptor (TcR)-CD3 complex
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK02746470T 2001-06-05 2002-06-05 P53-bindende T-cellereceptormolekyler og anvendelser deraf DK1546188T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29632401P 2001-06-05 2001-06-05
PCT/US2002/017785 WO2004018619A2 (en) 2001-06-05 2002-06-05 P53 binding t cell receptor molecules and uses thereof

Publications (1)

Publication Number Publication Date
DK1546188T3 true DK1546188T3 (da) 2008-10-27

Family

ID=31946570

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02746470T DK1546188T3 (da) 2001-06-05 2002-06-05 P53-bindende T-cellereceptormolekyler og anvendelser deraf

Country Status (11)

Country Link
US (1) US7456263B2 (https=)
EP (2) EP1546188B1 (https=)
JP (1) JP4447456B2 (https=)
CN (1) CN1692124B (https=)
AT (1) ATE405582T1 (https=)
AU (1) AU2002316190B8 (https=)
CA (1) CA2487779C (https=)
DE (1) DE60228504D1 (https=)
DK (1) DK1546188T3 (https=)
ES (1) ES2307770T3 (https=)
WO (1) WO2004018619A2 (https=)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7524601A (en) * 2000-06-05 2001-12-17 Sunol Molecular Corp T cell receptor fusions and conjugates and methods of use thereof
KR101131297B1 (ko) * 2003-11-10 2012-03-30 알토 바이오사이언스 코포레이션 가용성 티씨알 분자 및 이용 방법
US7994298B2 (en) 2004-09-24 2011-08-09 Trustees Of Dartmouth College Chimeric NK receptor and methods for treating cancer
EP2486049A1 (en) 2009-10-06 2012-08-15 The Board Of Trustees Of The UniversityOf Illinois Human single-chain t cell receptors
WO2011059836A2 (en) 2009-10-29 2011-05-19 Trustees Of Dartmouth College T cell receptor-deficient t cell compositions
US9273283B2 (en) 2009-10-29 2016-03-01 The Trustees Of Dartmouth College Method of producing T cell receptor-deficient T cells expressing a chimeric receptor
US12492376B2 (en) 2009-10-29 2025-12-09 The Trustees Of Dartmouth College T-cell receptor-deficient T cell compositions
WO2013033626A2 (en) 2011-08-31 2013-03-07 Trustees Of Dartmouth College Nkp30 receptor targeted therapeutics
WO2013169691A1 (en) 2012-05-07 2013-11-14 Trustees Of Dartmouth College Anti-b7-h6 antibody, fusion proteins, and methods of using the same
UA114108C2 (uk) 2012-07-10 2017-04-25 Борд Оф Ріджентс, Дзе Юніверсіті Оф Техас Сістем Моноклональне антитіло для застосування в діагностиці і терапії злоякісних пухлин і аутоімунного захворювання
WO2019067243A1 (en) * 2017-09-29 2019-04-04 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services T CELL RECEPTORS RECOGNIZING P53 MUTE
WO2019069125A1 (en) 2017-10-06 2019-04-11 Oslo Universitetssykehus Hf CHIMERIC ANTIGEN RECEPTORS
CN108060135A (zh) * 2017-12-26 2018-05-22 东莞赛尔生物科技有限公司 一种高效表达p53抑癌蛋白的t细胞、制备方法及应用
CA3095757A1 (en) 2018-04-06 2019-10-10 The Regents Of The University Of California Methods of treating glioblastomas
CA3096202A1 (en) 2018-04-06 2019-10-10 The Regents Of The University Of California Methods of treating egfrviii expressing glioblastomas

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4867973A (en) 1984-08-31 1989-09-19 Cytogen Corporation Antibody-therapeutic agent conjugates
US5057313A (en) 1986-02-25 1991-10-15 The Center For Molecular Medicine And Immunology Diagnostic and therapeutic antibody conjugates
WO1988007553A1 (fr) 1987-03-26 1988-10-06 Teijin Limited Procede de preparation d'un complexe d'anticorps
CA2076347C (en) 1990-02-20 1996-11-26 Ravinder K. Gupta Improved antibody-enzyme direct conjugates and method of making same
GB9200417D0 (en) 1992-01-09 1992-02-26 Bagshawe Kenneth D Cytotoxic drug therapy
US6399368B1 (en) 1992-01-17 2002-06-04 Board Of Regents, The University Of Texas System Secretion of T cell receptor fragments from recombinant Escherichia coli cells
ES2139012T3 (es) * 1992-05-26 2000-02-01 Univ Leiden Peptidos de la proteina p53 humana destinados para ser utilizados en composiciones que inducen una reaccion en los linfocitos t humanos, y linfocitos t citotoxicos especificos de la proteina p53 humana.
WO1994012520A1 (en) 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
WO1996004314A1 (en) 1994-07-29 1996-02-15 Dade International, Inc. Mhc complexes and uses thereof
WO1996013593A2 (en) 1994-10-26 1996-05-09 Procept, Inc. Soluble single chain t cell receptors
WO1996018409A1 (en) * 1994-12-14 1996-06-20 The Scripps Research Institute In vivo activation of tumor-specific cytotoxic t cells
US5830755A (en) 1995-03-27 1998-11-03 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services T-cell receptors and their use in therapeutic and diagnostic methods
US5869270A (en) 1996-01-31 1999-02-09 Sunol Molecular Corporation Single chain MHC complexes and uses thereof
CA2246333A1 (en) 1996-03-05 1997-09-12 The Scripps Research Institute Recombinant constructs encoding t cell receptors specific for human hla-restricted tumor antigens
US6127524A (en) 1996-10-18 2000-10-03 Dade Behring Inc. Binding molecules and computer-based methods of increasing the binding affinity thereof
WO1998039482A1 (en) 1997-03-07 1998-09-11 Sunol Molecular Corporation Fusion proteins comprising bacteriophage coat protein and a single-chain t cell receptor
ATE533784T1 (de) 1997-10-02 2011-12-15 Altor Bioscience Corp Lösliche, einzelkettige proteine des t- zellrezeptors
DE69936927T2 (de) 1998-10-21 2008-05-15 Altor Bioscience Corp., Miramar Polyspezifische bindemoleküle und deren verwendung
EP1287363A2 (en) 2000-05-25 2003-03-05 Sunol Molecular Corporation Modulation of t-cell receptor interactions
AU7524601A (en) 2000-06-05 2001-12-17 Sunol Molecular Corp T cell receptor fusions and conjugates and methods of use thereof
DE10109855A1 (de) 2001-03-01 2002-09-12 Stanislawski Thomas Polypeptide eines p53-Protein-spezifischen murinen alpha/beta T-Zell Rezeptors, diese kodierende Nukleinsäuren und deren Verwendung

Also Published As

Publication number Publication date
JP4447456B2 (ja) 2010-04-07
WO2004018619A3 (en) 2005-05-06
ES2307770T3 (es) 2008-12-01
ATE405582T1 (de) 2008-09-15
EP1546188A2 (en) 2005-06-29
DE60228504D1 (de) 2008-10-02
CA2487779A1 (en) 2004-03-04
WO2004018619A2 (en) 2004-03-04
CA2487779C (en) 2012-10-02
CN1692124A (zh) 2005-11-02
EP1546188B1 (en) 2008-08-20
AU2002316190B2 (en) 2009-01-22
EP2009019A1 (en) 2008-12-31
EP1546188A4 (en) 2005-12-21
US20080269113A1 (en) 2008-10-30
JP2005525128A (ja) 2005-08-25
CN1692124B (zh) 2012-05-30
AU2002316190A1 (en) 2004-03-17
AU2002316190B8 (en) 2009-01-29
US7456263B2 (en) 2008-11-25
AU2002316190A8 (en) 2004-04-08

Similar Documents

Publication Publication Date Title
DK1546188T3 (da) P53-bindende T-cellereceptormolekyler og anvendelser deraf
NO20053999D0 (no) Survivin-avledede peptider og bruken av dem
DK1124568T3 (da) Polyspecifikke bindingsmolekyler og anvendelser deraf
DE69730693D1 (de) Mhc-komplexe und ihre verwendungen
CY1109649T1 (el) Αντιγονα και συνθεσεις απο neisseria
DK0643726T3 (da) Peptider af humant p53-protein til anvendelse i sammensætninger, som inducerer humant T-celle-respons, og humane p53-protei
DK1187591T3 (da) IBD-associerede mikrobielle antigener og fremgangsmåder til at anvende samme
ATE533784T1 (de) Lösliche, einzelkettige proteine des t- zellrezeptors
CY1107881T1 (el) Τροποποιημενα πεπτιδια ως θεραπευτικοι παραγοντες
CY1110848T1 (el) Αντισωμα αντι ανθρωπου νοgo α kai h φαρμακευτικη του χρηση
HUP0401591A2 (hu) Új receptor-nukleinsavak és- polipeptidek
DE69940775D1 (de) Peptidzusammensetzung als immunogen zur allergiebehandlung.
ATE368688T1 (de) Peptide, deren herstellung und verwendung zur bindung von immunglobulinen
HUP0301812A2 (hu) Átvizsgálási (screening) eljárás
DE69931482D1 (de) Isolierte peptide die aminosäuresequenzen von ny-eso-1 entsprechen und an mhc-klasse i und mhc klasse ii moleküle binden, und deren verwendungen
EP1243923A4 (en) METHOD FOR FINDING A CURE FOR CANCER WITH THE INTERACTION OF P53 AND MORTALIN INTERACTIONS
RU2005106841A (ru) Эпитопы т-клеток в эритропоэтине
WO2001029220A3 (en) Mage-a12 antigenic peptides and uses thereof
RU2005108044A (ru) Эпитопы т-клеток в стафилококковом энтеротоксине в
ATE336579T1 (de) Isolierte mhc-klasse ii-bindende peptide, und deren verwendung
DK1436320T3 (da) T-celle-epitoper af cyn D 1-allergenet fra bermudagræspollen
HUP0301111A2 (hu) Potenciálisan immundomináns acetilkolin-receptor oligopeptideket tartalmazó gyógyszerkészítmények és alkalmazásuk
DE60308176D1 (de) Vorrichtung von peptid- oder proteindarstellung, verfahren zu deren herstellung und deren verwendung